Search

This study was conducted to address algal toxins using potassium permanganate through the control of biomass growth of algae under following conditions value 25±1 °C illumination intensity value 245microeinstein/m2/s, using the culture media Chu-10 Modified for the purpose of development algae. We treated algal toxins belonging to groups of Neurotoxins, Hepatotoxins, Pyriproxyfen, Emodin, Brevetoxins-10 (A) and Cytotoxins using concentrations of potassium permanganate represented by 2, 4, 8 and 16mg/l with alum concentration for each concentration of 30mg/l, as the removal rate reached to 100% of the toxin blooms in concentrations of 8 and 16mg/l respectively, through the examination of algal toxins mediated by GC–MASS compared to the standard, which diagnosed a range of algal toxins with C2H3C12NO formulas of synthetic C9H13NO2, C18H27NO3, C11H12N2O6, C11H17N3O, C10H17N3O, C9H15Br2NO, CH4N2O2, C11H17NO2, C13H9BrN2O3, C3H7NO4S, C20H29NO3, C15H10O5, C4H8O2and C2H2Cl3NO the concentrations 2 and 4mg/l turned toxic compounds into non-toxic compounds represented by C7H6O2, C5H6N2O, C12H11ClO4, C6H6O2, C12H10O4, C10H17N, C4H6O2and C5H6N2O. The results showed reduced primary productivity of algae chlorophyll a result of substance to stop chloroplast for vital activity through the influence of the concentration of potassium permanganate values 0.571, 1.142, 0.583 and 1.713mg/l respectively, compared to the standard of 114.2mg/l. As diagnosed types of Algae producing toxins are represented by Microcystis aeruginosa, Microcystis flosaquae, Oscillatoria amoena, Oscillatoria amphibian, Oscillatoria boryana, Oscillatoria limnetica, Oscillatoria perornata, Phormidium ambiguum, Lyngbya digueti, Lyngbya major, Lyngbya nordgaadii, Lyngbya spirulinoides, Nostoc carneum, Nostoc spongiforme, Anabaena augstumalis, Chroococcus indicusand Chroococcus minor, as the dry weight of live Algae producing toxins is 17.342g/l.

The cardiovascular actions of the magnesium ion at pharmacological concentrations include coronary and systemic vasodilatation, platelet inhibition, and antiarrhythmic effects. Magnesium has also been reported to protect myocardial tissue in experimental models of ischaemia and reperfusion. Several small clinical trials in suspected acute myocardial infarction have suggested that early mortality can be reduced by intravenous infusion of magnesium salts in the acute phase, but none has been of sufficient size to be conclusive. We therefore conducted a randomised, double blind, placebo controlled study in 2316 patients with suspected acute myocardial infarction who received either intravenous magnesium sulphate (8 mmol over 5 min followed by 65 mmol over 24 h) or physiological saline. The primary outcome measure was 28-day mortality, which was ascertained in 99·3% of patients. The groups were well balanced for prognostic factors. By intention-to-treat analysis mortality from all causes was 7·8% in the magnesium group and 10·3% in the placebo group (2p=0·04), a relative reduction of 24% (95% confidence interval 1-43%). Within the coronary care unit the incidence of left ventricular failure was reduced by 25% (7-39%) in the magnesium group (2p=0·009). There was no significant difference between the groups in the incidence of heart block or the use of antiarrhythmic drugs, direct-current cardioversion, or temporary pacing. Myocardial infarction was confirmed in 65% of each group, with closely similar rises in cardiac enzymes. The side-effects of magnesium treatment were transient flushing, related to speed of injection of the loading dose, and an increased incidence of sinus bradycardia (2p=0·02). Exploratory subgroup analyses of 28-day mortality did not indicate any effect modification by thrombolysis or aspirin, or by previous treatment with beta blockers, calcium antagonists, or diuretics. Intravenous magnesium sulphate is a simple, safe, and widely applicable treatment. Its efficacy in reducing early mortality of myocardial infarction is comparable to, but independent of, that of thrombolytic or antiplatelet therapy.

EPR spectra for isolated Ni2+ions in Sr1-xNixO display trigonal rather than octahedral symmetry, and reveal an anomalously large splitting of (20 ± 6) cm-1in the 3A2ground state. These unusual features are explained using a model based on quadratic Jahn-Teller coupling and a soft, localised, off-centre, mode of vibration.